CDC's Updated COVID-19 Vaccine Guidelines Unveiled
The U.S. CDC has issued guidance recommending a second dose of the 2024-2025 COVID-19 vaccine for individuals aged 65 and older, as well as for those who are moderately or severely immunocompromised. This guidance aims to enhance protection for these vulnerable groups in upcoming years.
The U.S. Centers for Disease Control and Prevention (CDC) has recommended a second dose of the 2024-2025 COVID-19 vaccine for individuals over the age of 65.
This guidance also applies to individuals who are moderately or severely immunocompromised, aiming to bolster their protection against the virus.
The decision comes as part of ongoing efforts to safeguard vulnerable populations, ensuring better community health outcomes as the pandemic continues to evolve.
(With inputs from agencies.)
- READ MORE ON:
- CDC
- COVID-19
- vaccine
- 2024
- 2025
- immunocompromised
- elderly
- health
- recommendation
- dose
Advertisement
ALSO READ
CMC Markets PLC's H1 2025 Financial Surge
World Bank Approves $2025-2026 Strategy to Support Zimbabwe’s Economic Growth, Social Resilience, and Climate Adaptation
Uttarakhand Gears Up for Grand 38th National Games in 2025
Jamia Millia Islamia Announces Vacant Seats for 2024-2025
Zelenskiy Eyes Strategic Shift to End Conflict by 2025